News

All Categories

06 October 2020

Vaxxas Announces $22 Million Award from U.S. Government to Advance Vaxxas Needle-Free HD-MAP™ Vaccine Patch Technology for Pandemic Response

26 September 2020

Healthcare investments at record highs amidst SARS-CoV-2 pandemic

07 September 2020

Could Vaxxas’ tiny patches enable a better COVID-19 vaccine?

25 August 2020

How Shippit got lean and profitable during COVID

News, The Australian

25 August 2020

Aussie e-bike subscription startup rides away with $16 million in funding and a brand new name to boot

News, Smart Company

25 August 2020

Subscription e-bike venture Bolt Bikes raises $16 million as it rebrands and expands globally

25 August 2020

E-bike start-up in the money as clean energy fund leads $16m round

News, The Australian Financial Review

25 August 2020

With $11 million in fresh capital, Bolt Bikes rebrands to Zoomo

12 August 2020

Blade Therapeutics Updates Enrollment Progress for Phase 2 Study of Lead Investigational Therapy BLD-2660 in Treating Patients with COVID-19 Pneumonia

10 August 2020

Blade Therapeutics Appoints Accomplished Biopharmaceutical Executive, Mark Timney, as Chairman of the Board

05 August 2020

OneVentures closes its first venture debt fund, the largest in Australia

03 August 2020

KiRA Biotech appoints Global Pharma Business Leader as Independent Board Chair

02 August 2020

FDA Approves Xeglyze™ for the topical treatment of head lice infestation

02 August 2020

Hatchtech gets lice treatment nod from FDA

News, The Australian Financial Review

22 July 2020

OneVentures’ credit fund reaches final close at $80m

News, The Australian Financial Review

22 July 2020

OneVentures Venture Credit Fund poised to invest $120M into Australian scaleups

20 June 2020

The Advantages of the Microneedle Array Patch

29 May 2020

Vaxxas announces that MSD exercises option to apply novel immune system activation platform for vaccine candidate

28 May 2020

Harro Höfliger and Vaxxas announce alliance to develop industrial‐scale aseptic processing line for vaccine products based on Vaxxas’ High Density Microarray Patch (HD‐MAP)

27 May 2020

Clinical Genomics announces publication of Additional positive data reinforcing key benefits of COLVERA®

19 May 2020

OneVentures expands team to internationalise its healthcare portfolio

30 April 2020

Clinical Genomics expands strategic relationship with Quest Diagnostics and further increases momentum for innovative first-line colorectal cancer screening blood test

24 March 2020

High-density microarray patch could provide alternative to syringe vaccine delivery

18 March 2020

Queensland researchers develop ‘vaccination patch’, backed by Bill Gates’ foundation